Medicamen Organics Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-40.19	40.47	26.24	9.69	1.01
Depreciation & Amortization	6.2	5.97	7.19	7.12	6.8
Other Operating Activities	-7	17.08	12.18	1.63	4.08
Change in Accounts Receivable	72.28	-91.52	-59.32	-45.23	12.84
Change in Inventory	-30.28	-13.47	-0.04	-14.17	-20.61
Change in Accounts Payable	-61.77	46.23	-19.19	24.81	4.81
Change in Other Net Operating Assets	14.82	-50.2	-3.69	10.32	-8.56
Operating Cash Flow	-45.95	-45.43	-36.62	-5.84	0.37
Capital Expenditures	-17.38	-24.47	-3.51	-2.89	-6.16
Other Investing Activities	0.22	0.95	0.13	0.08	0.23
Investing Cash Flow	-17.16	-23.53	-3.37	-2.81	-5.93
Short-Term Debt Issued	10.52	-	12.54	-	-
Long-Term Debt Issued	8.88	-	-	15.49	6.56
Total Debt Issued	19.4	-	12.54	15.49	6.56
Short-Term Debt Repaid	-	-3	-	-	-
Long-Term Debt Repaid	-	-0.04	-3.93	-	-
Total Debt Repaid	-	-3.03	-3.93	-	-
Net Debt Issued (Repaid)	19.4	-3.03	8.62	15.49	6.56
Issuance of Common Stock	30	105.4	38	-	-
Other Financing Activities	-14.56	2.36	-6.47	-6.12	-4.73
Financing Cash Flow	34.84	104.73	40.14	9.37	1.83
Miscellaneous Cash Flow Adjustments	0	-0	-0	-	-
Net Cash Flow	-28.27	35.77	0.15	0.72	-3.73
Free Cash Flow	-63.34	-69.9	-40.13	-8.73	-5.79
Free Cash Flow Margin	-27.99%	-18.30%	-15.88%	-3.94%	-2.76%
Free Cash Flow Per Share	-5.37	-6.32	-5.31	-1.46	-0.96
Cash Interest Paid	7.06	5.14	6.47	5.66	4.36
Cash Income Tax Paid	1.25	0.94	1.81	0.48	0.65
Levered Free Cash Flow	-51.77	-72.1	-52.37	-20.54	-10.79
Unlevered Free Cash Flow	-47.33	-69.11	-48.47	-17.01	-8.07
Change in Working Capital	-4.95	-108.95	-82.23	-24.27	-11.52